Clinical Trial Market Size is Expected to Grow at a CAGR of 4.3% and Overpass a Value of USD 184.61 Billion by 2034 | Future Market Insights
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.ukThe rare disease clinical trials market size is projected to be valued at US$ 12,566.14 million in 2023 and is expected to rise to US$ 31,715.25 million by 2033.
The Non-Alcoholic Steatohepatitis Clinical Trials Market Analysis report by Future Market Insights shows that global sales in 2021 were held at US$ 2.5 billion. With 7%, the projected market growth from 2022 to 2032
The market for AI-based clinical trial solution provider is expected to reach USD 2.2 billion in 2024 and USD 8.7 billion by 2034. A 14.3% CAGR is expected between 2024 and 2034 for a strong growth.
In 2023, the clinical alarm management market is expected to be worth US$ 3.0 billion. It is predicted to reach US$ 6.2 billion by 2033, rising at 7.5% CAGR from 2023 to 2033.
The clinical information system market is expected to record a CAGR of 8% during the forecast period, reaching a valuation of US$ 1560 Million by 2027.
According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.
The retail clinic market is expected to be valued at US$ 5,659.2 million in 2024 and reach US$ 12,308.7 million by 2034. The market is projected to grow at a CAGR of 8.1% during the forecast period.
The outpatient clinics market is scheduled to be worth US$ 40,761.7 million in 2023 and potentially escalate at a CAGR of 4.2% during the forecast period. In 2033, the outpatient clinics demand shall be worth US$ 61,372.4 million.
The global private office-based clinics market is anticipated to grow at a moderate CAGR during the forecast period from 2022 and 2032. Growth in the market is driven by rapidly expanding healthcare industry,
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trial-market-size-is-expected-to-grow-at-a-cagr-of-4-3-and-overpass-a-value-of-usd-184-61-billion-by-2034--future-market-insights-302193392.html
